SCHEMBL8709017

SCHEMBL8709017

COCOc1cccc(C=CC=O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNB2 O95067 3/20 0.62
CDK1 P06493 3/20 0.62
CDK4 P11802 3/20 0.62
CCNB1 P14635 3/20 0.62
CCND1 P24385 3/20 0.62
CCNB3 Q8WWL7 3/20 0.62
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAOA P21397 3/20 0.44
MAOB P27338 3/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
TRPA1 O75762 2/20 0.43
LMNA P02545 1/20 0.43
ALOX5 P09917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8709013 1.00 CCNB2 (0.62) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL18587009 0.86 CCNB2 (0.61) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL18587010 0.86 CCNB2 (0.61) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL9035424 0.84 CCNB2 (0.66) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL9035429 0.84 CCNB2 (0.66) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL29955275 0.83 NPC1 (0.60) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL950478 0.83 NPC1 (0.60) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL6373511 0.82 RELA (0.46) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL6373504 0.82 RELA (0.46) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL25259513 0.82 RELA (0.62) CCNB2CDK1CDK4CCNB1CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0844000-A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis SANKYO COMPANY LIMITED (JP) 1998-05-27 EP disclosed
US-5556864-A TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0600717-A1 Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis SANKYO COMPANY LIMITED (JP) 1994-06-08 EP disclosed